| NCT Number | NCT07260799 |
| Lead Sponsor | Tasso Inc.
Collaborators: American Research Labs |
| Conditions | Serum Analytes |
| Enrollment | 150 participants |
| Start Date | 2025-10-25 |
| Primary Completion | 2026-10-31 (estimated) |
| Study Completion | 2026-10-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-20 |